Ensysce Biosciences

ENSCNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.347 M

$0.43 +1.88%

Close of 22 Sept 2026

Revenue

$5.07M

#3279 by revenue

Earnings

—

Not reported

Shares outstanding

19,456,794

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#443ExicureXCUR$8.44M
#444SoligenixSNGX$8.38M
#445Ensysce BiosciencesENSC$8.35M
#446Traws PharmaTRAW$7.68M
#447CNS PharmaceuticalsCNSP$7.66M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Ensysce Biosciences, worth $444.2K. Grants and option exercises are excluded.

Bob G. Gower$444.2K
908,614 shares at $0.49 on 23 Apr 2026 · filed 18 Aug 2026

What if Ensysce Biosciences were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,553,903

Per share 3,622,151× higher

Bitcoin $1.74T

$89,513.98

Per share 208,657× higher

Nvidia $5.52T

$283,487.96

Per share 660,811× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Ensysce Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.